The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,810.00
Ask: 1,810.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,814.50
Low: 1,806.50
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight

Thu, 07th Oct 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

CITIGROUP RAISES LEGAL & GENERAL PRICE TARGET TO 336 (301) PENCE - 'BUY'

----------

MORGAN STANLEY CUTS GLAXOSMITHKLINE PRICE TARGET TO 1,555 PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS SCHRODERS TARGET TO 3,700 (3,890) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS HARGREAVES LANDSDOWN TARGET TO 1,381 PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS ABRDN PRICE TARGET TO 289 (305) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES PRUDENTIAL PRICE TARGET TO 1,764 (1,706) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES RENTOKIL INITIAL TARGET TO 645 (620) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN PRICE TARGET TO 3,500 (3,320) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES ANGLO AMERICAN PRICE TARGET TO 4,100 (3,900) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS ANGLO AMERICAN PRICE TARGET TO 3,700 (4,300) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS RIO TINTO PRICE TARGET TO 5,400 (6,910) PENCE - 'NEUTRAL'

----------

BERENBERG CUTS RIO TINTO PRICE TARGET TO 5,400 (6,900) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES ANTOFAGASTA PRICE TARGET TO 1,750 (1,700) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES GLENCORE PRICE TARGET TO 470 (430) PENCE - 'BUY'

----------

BERENBERG CUTS BHP GROUP PRICE TARGET TO 2,200 (2,300) PENCE - 'HOLD'

----------

JEFFERIES CUTS POLYMETAL PRICE TARGET TO 1,725 (1,900) PENCE - 'BUY'

----------

BERENBERG CUTS POLYMETAL PRICE TARGET TO 2,200 (2,300) PENCE - 'BUY'

----------

JEFFERIES CUTS FRESNILLO PRICE TARGET TO 1,280 (1,300) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES RELX PRICE TARGET TO 2,500 (2,430) PENCE - 'OUTPERFORM'

----------

UBS RAISES RELX PRICE TARGET TO 2,135 (2,040) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES TESCO PRICE TARGET TO 330 (300) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES TESCO PRICE TARGET TO 320 (310) PENCE - 'BUY'

----------

BARCLAYS RAISES TESCO PRICE TARGET TO 325 (310) PENCE - 'OVERWEIGHT'

----------

BERNSTEIN RAISES TESCO PRICE TARGET TO 330 (280) PENCE - 'OUTPERFORM'

----------

RBC CUTS BURBERRY PRICE TARGET TO 1,950 (2,160) PENCE - 'SECTOR PERFORM'

----------

FTSE 250

----------

MORGAN STANLEY RAISES CENTRICA TO 'OVERWEIGHT' (EQUAL WEIGHT) - TARGET 75 (58) PENCE

----------

MORGAN STANLEY CUTS MAN GROUP PRICE TARGET TO 253 (255) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS ASHMORE GROUP TARGET TO 376 (412) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 340 (360) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS HOMESERVE TARGET TO 1,020 (1,110) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK INITIATES MARSHALLS WITH 'BUY' - TARGET 885 PENCE

----------

BERENBERG RAISES HOCHSCHILD MINING TO 'BUY' ('HOLD') - TARGET 200 PENCE

----------

BERENBERG CUTS CENTAMIN PRICE TARGET TO 137 (138) PENCE - 'BUY'

----------

JEFFERIES CUTS CENTAMIN PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

RBC RAISES PAGEGROUP PRICE TARGET TO 760 (700) PENCE - 'OUTPERFORM'

----------

RBC CUTS TRITAX BIG BOX PRICE TARGET TO 260 (265) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES BRITVIC PRICE TARGET TO 1050 (900) PENCE - 'BUY'

----------

JEFFERIES RAISES TRAVIS PERKINS PRICE TARGET TO 2,220 (2,168) PENCE - 'BUY'

----------

JEFFERIES RAISES OXFORD INSTRUMENTS PRICE TARGET TO 2,445 (2,415) PENCE - 'HOLD'

----------

DZ BANK CUTS FAIR VALUE FOR TUI TO 2.00 (2.60) EUR - 'SELL'

----------

MORGAN STANLEY CUTS TUI PRICE TARGET TO 140 (160) PENCE - 'UNDERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES GEM DIAMONDS TO 'BUY' ('HOLD') - TARGET 80 (70) PENCE

----------

BERENBERG RAISES IMPAX GROUP PRICE TARGET TO 1,400 (1,360) PENCE - 'BUY'

----------

BERENBERG RAISES PENDRAGON PRICE TARGET TO 28 (27) PENCE - 'BUY'

----------

RBC RAISES CVS GROUP PRICE TARGET TO 3,100 (2,750) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES KENMARE RESOURCES PRICE TARGET TO 580 (530) PENCE - 'BUY'

----------

BERENBERG CUTS GRIFFIN PRICE TARGET TO 175 (200) PENCE - 'BUY'

----------

BERENBERG CUTS GREATLAND GOLD PRICE TARGET TO 26 (29) PENCE - 'BUY'

----------

BERENBERG RAISES CENTRAL ASIA METALS PRICE TARGET TO 320 (300) PENCE - 'BUY'

----------

BERENBERG RAISES NICHOLS PRICE TARGET TO 1,350 (1,200) PENCE - 'HOLD'

----------

BERENBERG RAISES FEVERTREE DRINKS PRICE TARGET TO 2,700 (2,500) PENCE - 'BUY'

----------

BERENBERG RAISES AG BARR PRICE TARGET TO 570 (450) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES SUPERMARKET INCOME REIT PRICE TARGET TO 136 (134) PENCE - 'BUY'

----------

JPMORGAN RAISES PETROFAC PRICE TARGET TO 170 (120) PENCE - 'NEUTRAL'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.